血清CA125结合B超对绝经后妇女卵巢恶性病变的预测价值

目的 通过了解绝经后妇女卵巢肿物的临床特点，探讨早期发现绝经后妇女卵巢恶性肿瘤的可行方法。方法 回顾分析302例经手术后病理证实为卵巢肿物的自然绝经后妇女的临床特点，采用B超结合血CA125的定量测定。结果 71．2％的绝经后卵巢肿物患者无自觉症状，38．7％为卵巢恶性肿瘤，BUS结合血CA125对卵巢恶性病变预测的敏感性为98．4％，特异性为57．9％，阳性预测值62．6％，阴性预测值98．1％。结论 对绝经后妇女实施妇科检查及B超的筛查结合血CA125的定量测定，有助于临床医生及时发现卵巢恶性肿瘤。

The predictive value of B ultrasound and serum CA125 for ovarian malignant neoplasm in postmenopausal women

Objective To figure out an optimal early detection of ovarian malignant neoplasm in postmenopausal women. Methods We reviewed the clinical findings in 302 postmenopausal women with ovarian neoplasm which was confirmed by postoperative pathologic examination, and analyzed the results of B ultrasound and serum CA 125 . Results 71 2% patients were asymptomatic, and 38 7% were with malignant ovarian neoplasm. Ultrasound combining with serum CA 125 was valuable in diagnosis of malignant neoplasm, with 98 4% sensitivity and 57 9% specificity. Conclusions It is helpful in early detection of ovarian malignant neoplasm in postmenopausal women by pelvic examination with B ultrasound and serum CA 125 .